The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to ...

Today, Industry Dive, the company behind BioPharma Dive, is combining with TechTarget’s technology websites and Informa ...

Using tumor-treating fields alongside chemotherapy improved patient survival, Novocure said. Elsewhere, Cytokinetics got a ...

At the center of a new licensing deal is an experimental medicine, PTC518, which is currently being tested in a roughly ...

Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s ...

Next-generation sequencing allows for critical insights into gene therapy products, which can help streamline and accelerate ...

Kronos is cutting 83% of its workforce, while Idorsia is considering eliminating as many as 270 jobs. Elsewhere, PTC ...

The biotechnology company, which sees itself as "pretty conservative," recently put out an ambitious long-term revenue ...

Dublin/Frankfurt, 27 November, 2024 - Merz Therapeutics launches iFlexo, a personalized digital solution aimed at enhancing ...

The Trump administration may also be more aggressive targeting specific sectors, such as pharmacy benefit managers. Although ...

Sarepta Therapeutics has turned to dealmaking to restock a drug pipeline analysts worried was growing thin, announcing Tuesday a deal with Arrowhead Pharmaceuticals that will give it four ...